ENTITY
Aurobindo Pharma

Aurobindo Pharma (ARBP IN)

86
Analysis
Health CareIndia
Aurobindo Pharma Limited manufactures and markets oral and sterile antibiotics, antibacterials, anti-ulcerants and other generic basic drugs. Products include semi-synthetic penicillin drugs like ampicillin and amoxycillinas well as antibiotics, which include cloxacillin and dicloxacillin. The Company also manufactures formulations like astemizole, domeperidone and omeprazole.
more
Refresh
31 May 2023 01:07Broker

Aurobindo Pharma Ltd - Number of Livers to Drive Topline

Aurobindo Pharma' reported PAT missed estimates by 5%. Consol. Revenue grew by 11.4% YoY, Gross margins decreased by 183 bps YoY and EBITDA margins...

Logo
247 Views
Share
11 Jan 2023 02:54Broker

Pharma - Q3FY23 - Earnings Preview

Low single-digit growth in the US market (due to intense competition) and low double-digit growth in the India business after Covid-19 business has...

Logo
297 Views
Share
26 Nov 2022 03:20Broker

Aurobindo Pharma - US Drags Down Overall Performance; Outlook Cautious

Aurobindo is a significant global generics player with 28 manufacturing facilities, including eight key formulations facilities in India and abroad...

Share
26 Nov 2022 02:55Broker

Aurobindo Pharma - Price Erosion in the US and Higher OPEX Impacts Earning

ARBP delivered a 2QYF23 earnings miss, led by lower-than-expected US and ARV sales. Sales from Europe (EU) were stable YoY in CC terms, with a...

Logo
366 Views
Share
25 Nov 2022 08:05Broker

Aurobindo Pharma (AURPHA) - US Drags Down Overall Performance; Outlook Cautious

Aurobindo is a significant global generics player with 28 manufacturing facilities, including eight key formulations facilities in India and abroad...

Share
x